| 9534053 |
Therapeutic human anti-IL-1R1 monoclonal antibody |
Brian Varnum, Chris Vezina, Alison Witte, Xueming Qian, Haichun Huang +1 more |
2017-01-03 |
$273,374,000 |
| 8710203 |
Therapeutic human anti-IL-1R1 monoclonal antibody |
Brian Varnum, Chris Vezina, Alison Witte, Xueming Qian, Haichun Huang +1 more |
2014-04-29 |
$232,192,000 |
| 8518407 |
Therapeutic human anti-IL-1R1 monoclonal antibody |
Brian Varnum, Chris Vezina, Alison Witte, Xueming Qian, Haichun Huang +1 more |
2013-08-27 |
$448,025,000 |
| 8409578 |
Methods for treating bone loss with antibodies to OPGL |
William J. Boyle, Jose Corvalan, C. Geoffrey Davis |
2013-04-02 |
$167,357,000 |
| 8236559 |
Therapeutic human anti-IL-1R1 monoclonal antibody |
Brian Varnum, Chris Vezina, Alison Witte, Xueming Qian, Haichun Huang +1 more |
2012-08-07 |
$138,668,000 |
| 8058418 |
Polynucleotides encoding heavy and light chains of antibodies to OPGL |
William J. Boyle, Jose Corvalan, C. Geoffrey Davis |
2011-11-15 |
$81,085,000 |
| 8043829 |
DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression |
John K. Sullivan, Joseph G. McGivern, Leslie P. Miranda, Hung Q. Nguyen, Kenneth W. Walker +4 more |
2011-10-25 |
$40,918,000 |
| 7910102 |
Methods of using conjugated toxin peptide therapeutic agents |
John K. Sullivan, Joseph G. McGivern, Leslie P. Miranda, Hung Q. Nguyen, Kenneth W. Walker +4 more |
2011-03-22 |
$114,930,000 |
| 7884054 |
Methods for identifying functional antibodies |
Chen Zhou, Wenyan Shen |
2011-02-08 |
$113,474,000 |
| 7820623 |
Conjugated toxin peptide therapeutic agents |
John K. Sullivan, Joseph G. McGivern, Leslie P. Miranda, Hung Q. Nguyen, Kenneth W. Walker +4 more |
2010-10-26 |
$81,898,000 |
| 7438910 |
Therapeutic human anti-IL1-R1 monoclonal antibody |
Brian Varnum, Chris Vezina, Alison Witte, Xueming Qian, Haichun Huang +1 more |
2008-10-21 |
|
| 7364736 |
Antibodies to OPGL |
William J. Boyle, Jose Corvalan, C. Geoffrey Davis |
2008-04-29 |
$154,205,000 |
| 7144731 |
SCF antibody compositions and methods of using the same |
Krisztina M. Zsebo, Robert A. Bosselman, Sidney V. Suggs |
2006-12-05 |
$91,213,000 |
| 6967029 |
Method for increasing hematopoietic progenitor cells by stem cell factor |
Krisztina M. Zsebo, Robert A. Bosselman, Sidney V. Suggs |
2005-11-22 |
$272,783,000 |
| 6852313 |
Method of stimulating growth of melanocyte cells by administering stem cell factor |
Krisztina M. Zsebo, Robert A. Bosselman, Sidney V. Suggs |
2005-02-08 |
$171,744,000 |
| 6841147 |
Stem cell factor compositions |
Krisztina M. Zsebo, Robert A. Bosselman, Sidney V. Suggs |
2005-01-11 |
$372,329,000 |
| 6759215 |
Method of preparing human stem cell factor polypeptide |
Krisztina M. Zsebo, Robert A. Bosselman, Sidney V. Suggs |
2004-07-06 |
$311,139,000 |
| 6248319 |
Method for increasing hematopoietic progenitor cells by stem cell factor polypeptides |
Krisztina M. Zsebo, Robert A. Bosselman, Sidney V. Suggs |
2001-06-19 |
|
| 6218148 |
DNS encoding stem cell factor |
Krisztina M. Zsebo, Robert A. Bosselman, Sidney V. Suggs |
2001-04-17 |
$741,130,000 |
| 6207802 |
Stem cell factor and compositions |
Krisztina M. Zsebo, Robert A. Bosselman, Sidney V. Suggs |
2001-03-27 |
$397,582,000 |
| 6207417 |
DNA encoding stem cell factor |
Krisztina M. Zsebo, Robert A. Bosselman, Sidney V. Suggs |
2001-03-27 |
|
| 6207454 |
Method for enhancing the effciency of gene transfer with stem cell factor (SCF) polypeptide |
Krisztina M. Zsebo, Robert A. Bosselman, Sidney V. Suggs |
2001-03-27 |
$397,582,000 |
| 6204363 |
Stem cell factor |
Krisztina M. Zsebo, Robert A. Bosselman, Sidney V. Suggs |
2001-03-20 |
$259,221,000 |
| 6197939 |
Placental-derived prostate growth factors |
Catherine L. Farrell, Rachel Yabkowitz |
2001-03-06 |
$939,878,000 |
| 6075008 |
Method for promoting cell proliferation and growth |
Catherine L. Farrell, Rachel Yabkowitz |
2000-06-13 |
$875,394,000 |